针对性护理对淋巴瘤化疗患儿不良反应的影响
|
摘要
目的探讨针对性护理对淋巴瘤化疗患儿不良反应的影响。方法选取2016年1月至2017年10月我院收治的淋巴瘤患儿106例为研究对象,随机将其等分为对照组和研究组,对照组采用常规护理,研究组采用针对性护理。比较两组患儿生活质量、不良反应发生情况。结果研究组患儿生活质量评分高于对照组(P <0. 05),研究组不良反应发生情况低于对照组(P <0. 05)。结论对淋巴瘤患儿化疗过程中实施针对性护理,效果显著,值得临床推广应用。
Objective To explore the effect of targeted nursing on adverse reactions in children with lymphoma chemotherapy. Methods To select106 children with lymphoma who were admitted to our hospital from January 2016 to October 2017 as the study subjects. They were randomly divided into control group and study group with the same number of patients. The control group was treated by routine nursing,while the study group was given targeted nursing. The quality of life and adverse reactions of the two groups were compared. Results The quality of life score in the study group was higher than that in the control group( P < 0. 05). The incidence of adverse reaction in the study group was lower than that in the control group( P < 0. 05). Conclusion Applying targeted care in children with lymphoma during chemotherapy has remarkable effects,which was worthy of clinical promotion and application.
Objective To explore the effect of targeted nursing on adverse reactions in children with lymphoma chemotherapy. Methods To select106 children with lymphoma who were admitted to our hospital from January 2016 to October 2017 as the study subjects. They were randomly divided into control group and study group with the same number of patients. The control group was treated by routine nursing,while the study group was given targeted nursing. The quality of life and adverse reactions of the two groups were compared. Results The quality of life score in the study group was higher than that in the control group( P < 0. 05). The incidence of adverse reaction in the study group was lower than that in the control group( P < 0. 05). Conclusion Applying targeted care in children with lymphoma during chemotherapy has remarkable effects,which was worthy of clinical promotion and application.
引文
[1]郑淑华,林雪棉.综合性护理干预对恶性淋巴瘤患者化疗后负性心理与生活质量的影响[J].护理实践与研究,2017,14(12):99-100.
[2]方文娟,李红,许能文.综合性护理干预对恶性淋巴瘤患者化疗后负性心理及生活质量的影响[J].中国现代医生,2015,53(32):149-152,156.
[3]许彭鹏,钱樱,陈秋生,等.滤泡性淋巴瘤国际预后指数2在利妥昔单克隆抗体维持治疗滤泡性淋巴瘤患者中的预后意义[J].中国实验血液学杂志,2017,25(2):426-430.
[4]Kelly KM,Sposto R,Hutchinson R,et al.BEACOPP chemotherapy is a highly effective regimen in children and adolescents with highrisk Hodgkin lymphoma:a report from the Children’s Oncology Group[J].Blood,2016,117(9):2596-2603.
[5]郭佳,朱易萍,高举,等.儿童成熟B细胞非霍奇金淋巴瘤/急性淋巴细胞白血病43例临床及预后分析[J].中国实验血液学杂志,2016,24(1):72-79.
[6]方晓,郑美珍,姜香琴,等.化疗期弥漫性大B细胞淋巴瘤患者皮肤损伤感染干预措施的研究[J].中华医院感染学杂志,2016,34(3):605-607.
[7]Elshenawy MA,Shahzad Rauf M,Elhassan TAM,et al.Survival analysis of patients with Hodgkin lymphoma who failed high dose chemotherapy and autologous stem cell transplant[J].Ann Hematol,2018,97(7):1229-1240.
[8]黄爽,金玲,杨菁,等.16例伴有睾丸侵犯的伯基特淋巴瘤患儿的临床特征及疗效分析[J].中华血液学杂志,2016,37(9):768-773.
[9]董林倩.护理干预对妇科肿瘤化疗患者生活质量的影响分析[J].首都食品与医药,2018,25(16):140.
[10]华银玲,杨如玉,李超,等.非霍奇金淋巴瘤患者化疗后肺部感染的危险因素及预防对策[J].中国地方病防治杂志,2016,9(3):296-297.
[11]Zhou T,Shen Q,Peng H,et al.Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab[J].Ann of Hematol,2017,97(1):141-147.
[12]孙舒君,徐连英.化疗间期随访路径表在淋巴瘤患者化疗中的应用[J].护理实践与研究,2016,13(6):100-102.
[2]方文娟,李红,许能文.综合性护理干预对恶性淋巴瘤患者化疗后负性心理及生活质量的影响[J].中国现代医生,2015,53(32):149-152,156.
[3]许彭鹏,钱樱,陈秋生,等.滤泡性淋巴瘤国际预后指数2在利妥昔单克隆抗体维持治疗滤泡性淋巴瘤患者中的预后意义[J].中国实验血液学杂志,2017,25(2):426-430.
[4]Kelly KM,Sposto R,Hutchinson R,et al.BEACOPP chemotherapy is a highly effective regimen in children and adolescents with highrisk Hodgkin lymphoma:a report from the Children’s Oncology Group[J].Blood,2016,117(9):2596-2603.
[5]郭佳,朱易萍,高举,等.儿童成熟B细胞非霍奇金淋巴瘤/急性淋巴细胞白血病43例临床及预后分析[J].中国实验血液学杂志,2016,24(1):72-79.
[6]方晓,郑美珍,姜香琴,等.化疗期弥漫性大B细胞淋巴瘤患者皮肤损伤感染干预措施的研究[J].中华医院感染学杂志,2016,34(3):605-607.
[7]Elshenawy MA,Shahzad Rauf M,Elhassan TAM,et al.Survival analysis of patients with Hodgkin lymphoma who failed high dose chemotherapy and autologous stem cell transplant[J].Ann Hematol,2018,97(7):1229-1240.
[8]黄爽,金玲,杨菁,等.16例伴有睾丸侵犯的伯基特淋巴瘤患儿的临床特征及疗效分析[J].中华血液学杂志,2016,37(9):768-773.
[9]董林倩.护理干预对妇科肿瘤化疗患者生活质量的影响分析[J].首都食品与医药,2018,25(16):140.
[10]华银玲,杨如玉,李超,等.非霍奇金淋巴瘤患者化疗后肺部感染的危险因素及预防对策[J].中国地方病防治杂志,2016,9(3):296-297.
[11]Zhou T,Shen Q,Peng H,et al.Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab[J].Ann of Hematol,2017,97(1):141-147.
[12]孙舒君,徐连英.化疗间期随访路径表在淋巴瘤患者化疗中的应用[J].护理实践与研究,2016,13(6):100-102.